Search

In the dynamic world of life sciences, the consultancy sector is undergoing a transformation as cost pressures increase, speed to market needs accelerate and technology permeates every aspect. Against this backdrop, clie...

Customer advocacy is not a trend, it’s a transformation. It represents a shift from service to stewardship and from expertise to empathy. It’s about recognising that behind every clinical milestone, every regulatory su...

Use Journals & Congresses to sort over 10,000 journals and congresses by submission date and lead times. Get your answer quickly so you can focus on your work. See how easy it is for yourself & request a demo. https://ow...

Biosimilars are gaining ground in APAC — but adoption depends on education. ICON’s latest blog dives into the real-world barriers to biosimilar uptake across Asia-Pacific, from low patient awareness to prescriber miscon...

Biosimilars are positively impacting healthcare in APAC — but awareness and trust remain critical hurdles. ICON explores how strategic education and engagement can unlock biosimilar adoption across Asia-Pacific, from em...

Recognising ICON’s Environmental, Social & Governance (ESG) commitment through our ICON Cares programme, we are honoured to be named one of the world’s best by TIME/ Statista. This list ranks the world’s 500 most sustain...

Today marks the final day of #OCTDACH, and our ICON team of experts is ready to welcome you at booth \#8. This is your chance to connect with leaders in clinical research and digital health who are driving innovation ac...

Nearly 30 million adults in the U.S. live with obstructive sleep apnea (OSA) – a chronic condition requiring ongoing monitoring. Until now, clinicians lacked a validated patient-reported tool for tracking treatment respo...

From imaging to cardiovascular care, AI-enabled devices are everywhere. But how do you navigate FDA regulations when there’s no unique pathway? Explore key insights on 510(k), De Novo, and lifecycle management in our new...

World Diabetes Day takes place on 14 November 2025. As the incidence of obesity and diabetes have grown in tandem to epidemic proportions, there is growing demand for treatments intended for patients with both conditions...

Did you know? JCA findings aren’t binding—but they do shape national HTA decisions. Learn how to tailor your strategy for each EU market while staying aligned with JCA requirements. Download the whitepaper: https://ow.ly...

Digital health technologies don’t just modernize clinical trials; they deliver measurable business value. From reducing trial timelines to improving patient retention and cutting costs, DHTs are proving their ROI across...